Home LiteratureArticle Details
PMID: 6893297 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S.

A platelet inhibitor protein with cytochalasin-like activity against actin polymerization in vitro.

Cell ·Vol. 21 ·No. 2 ·1980-09-00 ·Pages 439-44

Grumet M, Lin S

Abstract

We have obtained an inhibitor fraction containing cytochalasin-like activity from human platelets. Using a procedure involving DEAE-cellulose, hydroxyapatite and gel filtration column chromatography, we obtained a fraction from human platelets which apparently can compete with 3H--cytochalasin B for binding to spectrin-actin complexes from human erythrocytes. The inhibitor activity is nondialyzable, sensitive to heat and to trypsin and has a Stoke's radius of 40 A. This fraction stops nuclei-induced actin polymerization in 0.4 mM MgCl2 and reduces the viscosity of F actin to that of G actin, which suggests depolymerization of the filaments. These results suggest that the inhibitor fraction contains a protein which interacts with actin filaments and nuclei in a manner similar to that of cytochalasin B. It is possible that such a protein is involved in the control of cell motility by affecting assembly and disassembly of actin-containing microfilaments in vivo.

MeSH Terms
Actins/metabolism Binding Sites Blood Platelets/analysis Blood Proteins/isolation & purification,pharmacology Cytochalasin B/metabolism Erythrocytes Humans Polymers Spectrin/metabolism
Chemicals
Actins Blood Proteins Polymers Spectrin Cytochalasin B
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Grumet M
Lin S
Article Info
Journal
Cell
Abbr.
Cell
ISSN
0092-8674
Published
1980-09-00
Pages
439-44
Language
English
Region
United States
NLM ID
0413066
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]